Clinical Trial Update: Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients: a Multicenter Double Blind Randomised Controlled Trial [NA]

View source ↗

Summary

A multicenter randomized trial compares intermediate versus standard doses of enoxaparin for preventing venous thromboembolism in severe trauma patients; status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Severe Trauma Patient, Venous Thromboembolism | NA | Status: NOT_YET_RECRUITING